ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

January 10, 1997

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

CREG Announced for Premorbid Psychological Factors Study

August 27, 1976

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992